Clinical trial
STRATIFY TRIAL: Atrial Fibrillation Stratification Based on the Arrhythmia Perpetuation Mechanisms.
NCT04578275 is registered in ClinicalTrials.gov with Felipe Atienza as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- STRATIFY TRIAL: Atrial Fibrillation Stratification Based on the Arrhythmia Perpetuation Mechanisms.
- Lead sponsor
- Felipe Atienza
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 18, 2018
- Completion date
- December 31, 2021
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.